Home » Topics » BioWorld Science

BioWorld Science
RSS

Mosaic ImmunoEngineering presents structural details on cowpea mosaic virus

Nov. 2, 2021

APTA-1 shows promise in coronavirus-induced acute lung injury model

Nov. 2, 2021

Imugene and Eureka collaborate to evaluate oncolytic virus and T-cell therapy for solid tumors

Nov. 2, 2021

RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder

Nov. 2, 2021

iTeos Belgium describes new ENT1 inhibitors

Nov. 2, 2021

Cocrystal Pharma presents new antiviral compounds

Nov. 2, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 2, 2021

Mitobridge discloses new CD38 inhibitors

Nov. 2, 2021

GWAS meta-analysis identifies genetic variants linked to vertigo

Nov. 2, 2021

Almirall patents new TYK2 inhibitors

Nov. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...